Aclaris Therapeutics Inc (ACRS)

Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.09%1.48	1.63	2.00	1.30	3.30
Cost Of Revenue	13.30%0.19	0.22	0.40	0.53	0.54
	11.07%16.07	18.07	15.66	-	-
Research and Development	11.07%16.07	18.07	15.66	-	-
Costs And Expenses	11.76%22.83	25.87	24.19	24.03	20.45
Operating Income/Loss	11.94%-21.34	-24.24	-22.19	-22.73	-17.15
Nonoperating Income/Loss	3.70%2.83	2.73	2.37	2.94	2.54
	13.93%-18.51	-21.51	-19.82	-19.80	-14.61
Attributable To Parent	13.93%-18.51	-21.51	-19.82	-19.80	-14.61
Basic Average Shares	4.70%149.45	142.74	128.81	0.03	122.62
Diluted Average Shares	4.70%149.45	142.74	128.81	0.03	122.62
Basic Earnings Per Share	20.00%-0.12	-0.15	-0.15	-0.16	-0.12
Diluted Earnings Per Share	20.00%-0.12	-0.15	-0.15	-0.16	-0.12